Literature DB >> 6886016

Hyaline-vascular variant of angiofollicular lymph node hyperplasia with systemic manifestations and response to corticosteroids.

G P Summerfield, W Taylor, A J Bellingham, H J Goldsmith.   

Abstract

We report two cases of angiofollicular lymph node hyperplasia of the hyaline-vascular type. The patients were atypical in having systemic complications, which are much more commonly seen in the plasma cell variant of this disorder. In each case, the diagnosis was established some years after the initial presentation. Both patients presented with unusual systemic manifestations. The exact mechanism underlying the associated features is unknown, but these cases provide some evidence that the disease is primarily a vascular proliferative or inflammatory disorder. All manifestations of the disease responded to the administration of prednisolone with rapid reduction of dosage to less than 10 mg daily. Maintenance therapy may be required to prevent relapse.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6886016      PMCID: PMC498460          DOI: 10.1136/jcp.36.9.1005

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  6 in total

1.  Plasma cell giant lymph node hyperplasia responding to radiation therapy.

Authors:  D G Nordstrom; H H Tewfik; H B Latourette
Journal:  AJR Am J Roentgenol       Date:  1978-01       Impact factor: 3.959

2.  Angiomatous lymphoid-tissue hyperplasia.

Authors:  G Krasznai; I Juhász
Journal:  J Pathol       Date:  1969-01       Impact factor: 7.996

3.  Giant lymph node hyperplasia associated with thrombotic thrombocytopenic purpura.

Authors:  W D Couch
Journal:  Am J Clin Pathol       Date:  1980-09       Impact factor: 2.493

4.  Multicentric giant lymph node hyperplasia. A hyperimmune syndrome with a rapidly progressive course.

Authors:  E Bartoli; G Massarelli; G Soggia; F Tanda
Journal:  Am J Clin Pathol       Date:  1980-03       Impact factor: 2.493

5.  Giant lymph node hyperplasia (Castleman's disease) associated with temporal arteritis.

Authors:  P Lenner; E Lundgren
Journal:  Scand J Haematol       Date:  1981-10

6.  Remission of giant lymph node hyperplasia with anemia after radiotherapy.

Authors:  D D Weisenburger; R L DeGowin; P Gibson; J O Armitage
Journal:  Cancer       Date:  1979-08       Impact factor: 6.860

  6 in total
  9 in total

Review 1.  Castleman's disease in childhood: report of three cases and review of the literature.

Authors:  Piero Farruggia; Antonino Trizzino; Nunzia Scibetta; Giovanni Cecchetto; Patrizia Guerrieri; Emanuele S G D'Amore; Paolo D'Angelo
Journal:  Ital J Pediatr       Date:  2011-10-20       Impact factor: 2.638

2.  Efficacy of tocilizumab, a humanized neutralizing antibody against interleukin-6 receptor, in progressive renal injury associated with Castleman's disease.

Authors:  Akito Maeshima; Masao Nakasatomi; Daizo Henmi; Shin Yamashita; Yoriaki Kaneko; Takashi Kuroiwa; Keiju Hiromura; Yoshihisa Nojima
Journal:  CEN Case Rep       Date:  2012-03-17

Review 3.  Castleman's disease: from basic mechanisms to molecular therapeutics.

Authors:  Hazem E El-Osta; Razelle Kurzrock
Journal:  Oncologist       Date:  2011-03-25

4.  Castleman's disease of the mesorectum: report of a case.

Authors:  Mi Ri Hwang; Hee Jin Chang; Min Ju Kim; Guh Jung Seo; Sang Bum Yoo; Ji Won Park; Hyo Seong Choi; Jae Hwan Oh
Journal:  Surg Today       Date:  2011-01-26       Impact factor: 2.549

5.  Multicentric Castleman's disease in a Ghanaian adult.

Authors:  Y A Dei-Adomakoh; C Segbefia; I Ekem; A Taylor
Journal:  Ghana Med J       Date:  2013-06

Review 6.  An autopsy case of multicentric Castleman's disease associated with interstitial nephritis and secondary AA amyloidosis.

Authors:  Yuriko Morita-Hoshi; Shuji Tohda; Osamu Miura; Nobuo Nara
Journal:  Int J Hematol       Date:  2007-12-08       Impact factor: 2.490

7.  Unexpected uptake of technetium 99m hexakis-2-methoxy-isobutylisonitrile in giant lymph node hyperplasia of the mediastinum (Castleman's disease).

Authors:  C Aktolun; H Bayhan; B Celasun; M K Kir
Journal:  Eur J Nucl Med       Date:  1991

8.  Castleman's Disease, a Case report.

Authors:  Ranga Reddy; Ankit Singhania; Ajay George; Ranjan Kumar; Sanjay Kumar
Journal:  Iran J Otorhinolaryngol       Date:  2011

9.  A rare case of renal thrombotic microangiopathy associated with Castleman's disease.

Authors:  Anubha Mutneja; L Nicholas Cossey; Helen Liapis; Ying Maggie Chen
Journal:  BMC Nephrol       Date:  2017-02-10       Impact factor: 2.388

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.